Background and Purpose-We evaluated the association between electrocardiographic left atrial abnormality (ECG-LAA) and ischemic stroke, especially whether ECG-LAA provides additional prognostic information to that provided by echocardiography. Methods-A population-based, case-control study included 146 patients with first ischemic stroke and 195 age-, gender-, and race/ethnicity-matched community control subjects. ECG-LAA was defined as either P-wave duration Ͼ120 ms or P-terminal force in precordial lead V 1 (PTFV 1 ) Ͼ40 ms⅐mm. 
L eft atrial (LA) enlargement is a risk factor for ischemic stroke. 1,2 LA anteroposterior diameter by 2D echocardiography (Echo-LAE) is commonly used for evaluating the LA size but has limitations related to the LA irregular geometry and physical constraints imposed by the spine and sternum. In clinical studies, Echo-LAE provided contradictory results as a predictor for ischemic stroke. For chronic atrial fibrillation, Echo-LAE was of no value for predicting thromboembolism, 3 whereas LA size was a main predictor of stroke. 4 Reasons for these conflicting data remain unclear.
Assessment of electrocardiographic LA abnormality (ECG-LAA) is a noninvasive and universally available method. ECG-LAA is observed in the setting of hypertensive heart disease 5 and is known to reflect increases in left ventricular (LV) filling pressure and the consequent remodeling process. 6 Reliable ECG-LAA criteria might offer a simple and inexpensive way to predict the risk of ischemic stroke in addition to echocardiographic LA assessment.
Methods
Patients were drawn from the Northern Manhattan Stroke Study (NOMASS), a community-based epidemiological study for assessing stroke incidence, risk factors, and prognosis in the multiethnic population of northern Manhattan. 7 From June 1993 through December 1996, 234 patients (Ͼ39 years of age) with computed tomography-or MRI-confirmed first-time ischemic stroke and 286 stroke-free controls were recruited. A total of 88 stroke patients and 91 control subjects were excluded because of absence of native P-waves on the ECG (eg, atrial fibrillation, pacemaker rhythm), leaving 146 stroke patients and 195 control subjects.
Echocardiographic and electrocardiographic studies were interpreted blinded to case-control status and other clinical characteristics. Interobserver and intraobserver variability for variables measured ranged between 8% and 10%. LA enlargement was defined as (1) a P-wave duration in limb leads Ͼ120 ms, and (2) an area subtended by the terminal negative component of a biphasic P-wave in precordial lead V 1 (PTFV 1 ) Ͼ40 ms ⅐ mm. 8 The area for PTFV 1 was calculated by multiplication of the duration and depth of the waveform. LA diameter was measured by 2D transthoracic echocardiography at the level of the aortic valve and normalized by the subject's body surface area. Values for normalized LA diameters were divided into quartiles, with the highest quartile considered LA enlargement.
Univariate and multivariate logistic regression analysis was used to test the association between ECG-LAA and ischemic stroke. Multivariate analysis was used to determine the odds ratio (OR) for ECG-LAA and ischemic stroke after adjusting for established stroke risk factors. Echocardiographically determined LA index (continuous variable) was included in a second multivariate model to determine whether the association of ECG-LAA and ischemic stroke was independent of echocardiographic measurements. Echocardiographically derived LV mass index (continuous variable) was also included in the model.
Results
Demographics and measured echocardiographic parameters are shown in Table 1 . For stroke patients, ECG-LAA assessed by the P-wave interval was noted in 2.7% and by PTFV 1 in 54%. The sensitivity and specificity of PTFV 1 was 54% and 62%, with the likelihood ratio for a positive and negative test of 1.4 and 0.8, respectively. The positive and negative predictive values were 51% and 64%, respectively. The stroke risk associated with Echo-LAE and ECG-LAA is reported in Table 2 . Among the ECG-LAA criteria studied, PTFV 1 was found to be associated with stroke in multivariate analysis (OR, 2.35; 95% CI, 1.29 to 4.18). The association remained significant after adjustment for Echo-LAE (OR, 2.31; 95% CI, 1.28 to 4.17).
The effect of PTFV 1 on stroke risk was strongly dependent on LV mass. After adjustment for other stroke risk factors, a strong increase in stroke risk with PTFV 1 Ͼ40 ms ⅐ mm was observed only in subjects in the 2 highest quartiles of LV mass index (Figure) . The adjusted OR for stroke in subjects in the upper half of LV mass distribution was 4.5 (95% CI, 2.20 to 9.15), whereas for those in the lower half, it was 0.58 (95% CI, 0.20 to 1.65). A highly significant interaction between PTFV 1 Ͼ40 ms⅐mm and LV mass on the stroke risk was observed (Pϭ0.0008).
Discussion
The finding that ECG-LAA is related to ischemic stroke is new and of interest. Although sensitivity and specificity of ECG-LAA for stroke diagnosis were modest, the strength of the association between ECG-LAA and ischemic stroke was of a similar magnitude to that of Echo-LAE and stroke. Moreover, the association between PTFV 1 and stroke remained significant even after adjusting for the presence of Echo-LAE, which suggests that ECG-LAA may be used to supplement the role of Echo-LAE for assessing the risk of ischemic stroke. Because Echo-LAE measurements carry certain limitations because of irregular LA geometry, ECG-LAA, which reflects global electrophysiological changes secondary to atrial remodeling, could overcome these limitations.
Of all criteria for LA abnormality, PTFV 1 is the most commonly used and consistent. 8 Therefore, it is not entirely surprising that PTFV 1 was more sensitive than a wide P-wave for predicting ischemic stroke. However, ECG patterns that reflect a change in LA morphology can be secondary to multiple factors, including electrical remodeling and other pathological changes, and might not be attributable to a change in size. 9 The electrophysiological effects of stroke itself can be a potential confounder as well. LA size is significantly associated with LV mass, and any condition causing LV hypertrophy (LVH) may produce Echo-LAE as a secondary phenomenon. The association between PTFV 1 and stroke in our study was limited to subjects with increased LV mass, and a strong interaction was noted. We reported previously on the influence of LVH on the association between LA size and stroke, especially in women. 2 The relationship between ECG LVH and echo-calculated LV mass for risk of ischemic stroke has also been demonstrated. 10 The present data suggest that a simple ECG-derived parameter of LA abnormality may help refine the prediction of stroke risk in subjects with increased LV mass. LA abnormality, and possibly an associated tendency to develop atrial arrhythmias, might also be involved in the explanation of the well-known association of LVH with stroke.
Conclusions
A PTFV 1 Ͼ40 ms⅐mm is strongly and independently associated with ischemic stroke in subjects in the upper half of echocardiographic LV mass distribution. Additional studies are necessary to define the complex factors linking LV mass, LA size, and LA electrical abnormalities to ischemic stroke.
